Filter
Period
Filter by
recent search
Showing: 1 – 05 of 124 Regulated Information
–
09 August 2022
09 August 2022
LinkedIn
Facebook
Voting rights on 31 July 2022
This article or press release has no online content. Please download the associated documents for more information.
–
09 August 2022
09 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
05 August 2022
05 August 2022
LinkedIn
Ipsen extends expiration date of tender offer for Epizyme, Inc. to 11 August 2022
PARIS, FRANCE, 5 August 2022 – Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the…
–
02 August 2022
02 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 25 July to 29 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
28 July 2022
28 July 2022
LinkedIn
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022: